Encapsulation of alendronate sodium by nanoprecipitation and double emulsion: From preparation to in vitro studies

被引:43
作者
Miladi, K. [1 ,2 ,3 ,4 ]
Sfar, S. [4 ]
Fessi, H. [1 ,2 ,3 ]
Elaissari, A. [1 ,2 ,3 ]
机构
[1] Univ Lyon, F-69622 Lyon, France
[2] Univ Lyon 1, F-69622 Villeurbanne, France
[3] Univ Lyon 1, CNRS, UMR 5007, Lab Automat & Genie Proc,LAGEP CPE 308G, F-69622 Villeurbanne, France
[4] Univ Monastir, Lab Pharm Galen, Monastir 5000, Tunisia
关键词
Alendronate sodium; Double emulsion evaporation; In vitro; Nanoparticles; Nanoprecipitation; Osteoporosis; Polycaprolactone; LOADED PLGA NANOPARTICLES; DELIVERY; FORMULATION; RELEASE; POLYMER; POLY(EPSILON-CAPROLACTONE); BISPHOSPHONATES; NANOSUSPENSIONS; MICROSPHERES; CYTOTOXICITY;
D O I
10.1016/j.indcrop.2015.01.079
中图分类号
S2 [农业工程];
学科分类号
0828 ;
摘要
Alendronate sodium is an active molecule indicated as first line regimen for osteoporosis treatment. Use of this drug presents, however, some shortcomings such as low oral bioavailability and gastrointestinal mucosa irritation. Nanotechnology remains an attractive approach to overcome such limitations of conventional pharmaceutical forms. However, encapsulation of hydrophilic molecules like alendronate represents a real challenge. Preparation, characterization and drug release behavior of polycaprolactone based nanoparticles loaded with alendronate sodium were investigated in this work. Two strategies were used to prepare these nanocarriers: double emulsion evaporation and nanoprecipitation. Operating conditions were monitored to produce biocompatible nanopartides with good properties. Both techniques gave nanoparticles with mean diameter in the range of 200-450 nm. Encapsulation efficiency of selected formulae reached 34% for double emulsion and 18% for nanoprecipitation, respectively. Highest drug loading was 20.7% for double emulsion and 8.2% for nanoprecipitation, respectively. For both methods, an increase of polymer molecular weight and polymer amount led to an increase of particle size. For nanoprecipitation, oil to water phase exerted also a significant effect on particle size. The increase of stabilizer amount or the use of rotoevaporation rather than continuous stirring at ambient temperature decreased particles size. Prepared nanoparticles exhibited sustained release of alendronate. When the same polymer amount and molecular weight was used, drug release of the selected formulae was faster for nanoparticles formulated by the nanoprecipitation method. However, release profiles were similar for both techniques with a first rapid release phase followed by a more prolonged phase. Analysis of in vitro release data showed also that active release mechanism relied on a combination of drug diffusion and polymer relaxation phenomena. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:24 / 33
页数:10
相关论文
共 41 条
  • [1] [Anonymous], 2009, The Complete Drug Reference, Martindale
  • [2] Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles
    Bilati, U
    Allémann, E
    Doelker, E
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) : 67 - 75
  • [3] Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content
    Budhian, Avinash
    Siegel, Steven J.
    Winey, Karen I.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (02) : 367 - 375
  • [4] Preparation and Characterization of Solid Lipid Nanoparticles Loaded with Racemic Mitotane
    Camerin Grando, Carolina Ribeiro
    Guimaraes, Carla Aiolfi
    Mercuri, Lucildes Pita
    Matos, Jivaldo do Rosario
    Andrade Santana, Maria Helena
    [J]. JOURNAL OF COLLOID SCIENCE AND BIOTECHNOLOGY, 2013, 2 (02) : 140 - 145
  • [5] Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics
    Cauchetier, E
    Deniau, M
    Fessi, H
    Astier, A
    Paul, M
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) : 273 - 281
  • [6] Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics
    Chorny, M
    Fishbein, I
    Danenberg, HD
    Golomb, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) : 389 - 400
  • [7] Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis
    Cohen-Sela, Einat
    Rosenzweig, Ohad
    Gao, Jianchuan
    Epstein, Hila
    Gati, Irith
    Reich, Reuven
    Danenberg, Haim D.
    Golomb, Gershon
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 113 (01) : 23 - 30
  • [8] A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles
    Cohen-Sela, Einat
    Chorny, Michael
    Koroukhov, Nickolay
    Danenberg, Haim D.
    Golomb, Gershon
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 133 (02) : 90 - 95
  • [9] Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation
    Contado, Catia
    Vighi, Eleonora
    Dalpiaz, Alessandro
    Leo, Eliana
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (2-3) : 703 - 711
  • [10] Pharmacokinetics/pharmacodynamics of bisphosphonates - Use for optimisation of intermittent therapy for osteoporosis
    Cremers, SCLM
    Pillai, GC
    Papapoulos, SE
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (06) : 551 - 570